Stuart Jamieson (Lonza)

article

Optimising bispecific antibody clonal cell selection with high-throughput analytics

It is possible to manufacture monoclonal antibodies using traditional methods,…

22 December 2022 | By Alice Harrison (Lonza), Stuart Jamieson (Lonza)

It is possible to manufacture monoclonal antibodies using traditional methods, but the challenges inherent in bispecific antibodies such as low titer, mismatched chains, unwanted fragments and higher aggregation levels require a heightened analytical focus on clonal cell selection. Here, Stuart Jamieson and Alice Harrison at Lonza discuss high-throughput analytical strategies…

article

Upstream Bioprocessing In-Depth Focus 2022

Articles on high-throughput analytics for optimising bsAb clonal cell selection…

21 December 2022 | By European Pharmaceutical Review

Articles on high-throughput analytics for optimising bsAb clonal cell selection and a technology to overcome buffer preparation bottlenecks.

article

European Pharmaceutical Review Issue 6 2022

This issue includes articles on Raman mapping of pharmaceutical tablets,…

13 December 2022 | By European Pharmaceutical Review

This issue includes articles on Raman mapping of pharmaceutical tablets, delivery options for mRNA therapeutics, the use of high-throughput analytics for clonal cell selection and much more...